CAPRA Annual Education Day 2025 Post Event Resources

Explore New Regulatory Insights at
HYBRID ANNUAL EDUCATION DAY  2025
Tuesday,  June 17, 2025  

For Registered Attendees Only

 Hybrid Annual Education Day 2025 
PRESENTATIONS & MATERIALS

Welcome to the official collection of presentations and materials from CAPRA Hybrid Education Day 2025!

This year’s event brought together regulatory professionals, industry leaders, and innovators to explore the latest advancements, challenges, and trends shaping the pharmaceutical landscape.

Whether you attended Education Day or are catching up now, these resources provide valuable insights, expert perspectives, and practical takeaways to support excellence in regulatory affairs and beyond. Dive into this comprehensive content to stay informed and ahead in your field.


CAPRA Education Day Committee


Annual Education Day Speakers
Click on the speakers' picture to view their bio.

Ravneet Kaur

Ravneet Kaur 

Health Canada

MPharm,Senior Regulatory Affairs Officer, NNHPD

Dr. Maxime Sasseville

Dr. Maxime Sasseville

Health Canada

Manager, Oncology Division 2, PDD

Jennifer Grandy

Jennifer Grandy

Health Canada

Director, Governance and Bilateral Agreements, Office of Pharmaceuticals ManagementStrategies

Oxana Iliach

Oxana Iliach

Certara

Senior Director Regulatory Strategy

Catherine Sullivan

Catherine Sullivan

Health Canada

Regulatory Affairs Specialist, New Substances Assessment and Control Bureau

Doris Simcich

Doris Simcich

AstraZeneca

Global Senior Director Operational Excellence

Betsy Luo

Betsy Luo

AstraZeneca

R&D IT Business Analyst

Brian Randall

Brian Randall

Innomar Strategies Inc. (a division of Cencora) 

Director Quality Assurance

 

TimeTopic Guest SpeakerDuration
8:00 - 9:00 amRegistration, Networking  and Breakfast 60 mins
9:00 - 9:15 amWelcoming Remarks 15 mins
9:15 - 10:00 am

How to Reduce Labelling Clarifaxes

 

Presentation

 

 


Ravneet Kaur,
MPharm, Senior Regulatory Affairs Officer, NNHPD,
 Health Canada 
Followed by Questions and Answers 

45 mins
10:00 - 10:40 am

Health Canada and International Collaboration Initiatives (i.e., ORBIS, ACCESS, etc.)

Presentation

Dr. Maxime Sasseville,
Manager, Oncology Division 2, PDD, Health Canada
Followed by Questions and Answers

 

40 mins
10:40 - 11:00 amCoffee Break, Networking and Visit Vendor Booths 20 mins
11:00 - 11:40 am

National Strategy for Drugs for Rare Diseases 

Presentation

 

Jennifer Grandy,
Director, Governance and Bilateral Agreements, Office of Pharmaceuticals Management Strategies, Health Canada
Followed by Questions and Answers

 

40 mins
11:40 - 12:20 pmRare Diseases: Regulatory landscape and market access

 

 

Presentation

Oxana Iliach,
Senior Director Regulatory Strategy, Certara
Followed by Questions and Answers

 

40 mins
12:20 - 1:20 pmLunch Break, Networking and Visit Vendor Booths 60 mins
1:20 - 2:00 pm

New Substances Notifications (NSN) for Cell and Gene

Therapy Organisms 


Presentation

 

 

 

Catherine Sullivan,
Regulatory Affairs Specialist, New Substances Assessment and Control Bureau, Health Canada
Followed by Questions and Answers

 

40 mins
2:00 - 2:40 pm

Enhancing Regulatory Through Artificial Intelligence (AI) Innovations

 

Presentation

Doris Simcich,
Global Senior Director Operational Excellence, AstraZeneca
 
Betsy Luo,
R&D IT Business Analyst, AstraZeneca
Followed by Questions and Answers

 

40 mins
2:40 - 3:00 pm

Coffee Break, Networking and Visit Vendor Booths

 


20 mins
3:00 - 3:40 pm

DEL Developments: Where We Stand and What’s Next? 

 

Presentation

Brian Randall,

Director Quality Assurance, Innomar Strategies Inc. (a division of Cencora) 
Followed by Questions and Answers

 

40 mins
3:40 - 4:00 pmClosing Remarks
 CAPRA Education Day Committee20 mins

Registration & Tickets
(HST will be added at time of checkout)
Registration Deadline: June 10, 2025

Thank You to Our Sponsors

We extend our sincere gratitude to the generous sponsors of CAPRA Education Day 2025. Your commitment plays a crucial role in bringing together leading experts in Pharmaceuticals and Regulatory Affairs, fostering collaboration, and driving industry innovation.  Your support helps ensure the success of this vital knowledge-sharing platform, empowering professionals to exchange insights, explore new developments, and shape the future of Regulatory Affairs.

Thank you for being an integral part of this event and for your continued dedication to advancing the industry!

Click on our sponsors' logos to view more resources.

Sponsorship & Vendor Booth Opportunities

For any questions you may have, please email administrator@capra.ca.

HST will be added at the time of checkout.